4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9 daahirnimo>98.5% (HPLC) Lenvatinib Mesylate Warshada Dhexe

Sharaxaad Gaaban:

Magaca: 4-Chloro-7-Methoxyquinoline-6-Carboxamide

CAS: 417721-36-9

Daahirsanaanta:>98.5% (HPLC)

Muuqashada: Caddaan-ka-baxsan ilaa budada jaalaha ah ee fudud

Dhexdhexaadiyaha Lenvatinib Mesylate CAS 857890-39-2

Tayada Sare, Wax Soo Saarka Ganacsiga

E-Mail: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Guryaha Kiimikada:

Magaca Kiimikada 4-Chloro-7-Methoxyquinoline-6-Carboxamide
La mid ah 4-Chloro-7-Methoxy-6-Quinolinecarboxamide;Lenvatinib wasakhnimada 12;Lenvatinib wasakh B;Lenvatinib wasakh LFS-B
Lambarka CAS 417721-36-9
Lambarka CAT RF-PI1971
Heerka Saamiyada Kaydka dhexdiisa, Awoodda Wax-soo-saarka 50MT/Sannadka
Qaanuunka molecular C11H9ClN2O2
Miisaanka Molecular 236.65
Meesha dhalaalaysa >205 ℃ (dac.)
Cufnaanta 1.380± 0.060 g/cm3
Summada Kiimikada Ruifu

Tilmaamaha:

Shayga Tilmaamaha
Muuqashada Ka-bax-caddan ilaa budada jaalaha ah ee khafiifka ah
Daahirnimada / Habka Falanqaynta > 98.5% (HPLC)
Khasaare xagga qalajinta <0.50%
Hadhaaga dabka <0.50%
Wadarta wasakhda <1.50%
Proton NMR Spectrum Waafaqsan Qaab-dhismeedka
Heerka Imtixaanka Heerka Ganacsiga
Isticmaalka Dhexdhexaadiyaha Lenvatinib Mesylate (CAS: 857890-39-2)

Xidhmada & Kaydinta:

Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka

Faa'iidooyinka

1

FAQ:

Codsiga:

4-Chloro-7-Methoxyquinoline-6-Carboxamide (CAS: 417721-36-9) waxaa inta badan loo isticmaalaa sidii dhexe ee Lenvatinib Mesylate (CAS: 857890-39-2).Waxaa sameeyay Eisai Inc., lenvatinib mesylate waa vascular endothelial factor factor reseptor (VEGF) inhibitor kaas oo leh waxqabad ka dhan ah VEGF subtypes 1, 2, iyo 3 waxaana ansixiyay FDA 2015 si loogu daaweeyo kansarka qanjirka thyroid ee kala duwan soo noqnoqda, metastatic, ama horusocod ah oo aan ka jawaabin daaweynta iodine radioactive.Bishii Maajo 2016, FDA waxay oggolaatay daawada sida isku-darka daaweynta weligeed ah ee daaweynta kansarka unugyada kelyaha ee horumarsan.Sababtoo ah VEGF (iyo fibroblast factor factor reseptors, oo loo yaqaan FGFRs) ayaa loo maleynayaa inay door ka ciyaaraan waddooyinka calaamadaha wadnaha, VEGF2R iyo FGFR waxay u maleynayaan inay yihiin hababka ka dambeeya saameynta asaasiga ah ee lenvatinib mesylate, taas oo ah hypertension.

Halkan ku qor fariintaada oo noo soo dir